Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avantor, Inc. (AVTR) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avantor, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1722482.
Total stock buying since 2019: $14,407,005.
Total stock sales since 2019: $3,122,734,034.
Total stock option exercises since 2019: $28,441,894.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 175,000 | $2,184,000 | 13,948 | $222,206 | 0 | $0 |
| 2024 | 0 | $0 | 25,194 | $623,880 | 0 | $0 |
| 2023 | 0 | $0 | 76,949 | $1,776,614 | 0 | $0 |
| 2022 | 82,500 | $1,719,297 | 134,658 | $4,887,925 | 59,418 | $1,096,262 |
| 2021 | 300 | $10,900 | 3,022,562 | $103,260,012 | 1,524,256 | $22,801,025 |
| 2020 | 0 | $0 | 155,315,987 | $3,001,442,589 | 2,840,380 | $4,544,607 |
| 2019 | 641,654 | $10,492,808 | 643,654 | $10,520,808 | 641,143 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 100,000 | $1,256,000 | 3,476 | $39,591 | 0 | $0 |
| 2025-05 | 75,000 | $928,000 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 10,472 | $182,615 | 0 | $0 |
| 2024-09 | 0 | $0 | 3,525 | $88,336 | 0 | $0 |
| 2024-03 | 0 | $0 | 3,685 | $94,446 | 0 | $0 |
| 2024-02 | 0 | $0 | 17,984 | $441,098 | 0 | $0 |
| 2023-09 | 0 | $0 | 7,577 | $156,389 | 0 | $0 |
| 2023-08 | 0 | $0 | 25,000 | $536,750 | 0 | $0 |
| 2023-04 | 0 | $0 | 1,498 | $31,727 | 0 | $0 |
| 2023-03 | 0 | $0 | 3,914 | $97,850 | 0 | $0 |
| 2023-02 | 0 | $0 | 38,960 | $953,898 | 0 | $0 |
| 2022-11 | 82,500 | $1,719,297 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 58,603 | $1,845,775 | 0 | $0 |
| 2022-03 | 0 | $0 | 2,027 | $69,870 | 0 | $0 |
| 2022-02 | 0 | $0 | 3,059 | $103,363 | 0 | $0 |
| 2022-01 | 0 | $0 | 70,969 | $2,868,917 | 59,418 | $1,096,262 |
| 2021-12 | 0 | $0 | 190,305 | $7,642,024 | 90,305 | $2,020,150 |
| 2021-11 | 0 | $0 | 240,804 | $9,426,481 | 80,000 | $1,856,000 |
| 2021-10 | 0 | $0 | 100,000 | $3,994,000 | 0 | $0 |
| 2021-09 | 0 | $0 | 241,300 | $9,931,881 | 0 | $0 |
| 2021-08 | 0 | $0 | 117,383 | $4,577,710 | 0 | $0 |
| 2021-07 | 300 | $10,900 | 105,568 | $3,899,822 | 81,125 | $1,882,100 |
| 2021-06 | 0 | $0 | 556,305 | $18,090,633 | 487,700 | $1,579,440 |
| 2021-05 | 0 | $0 | 647,269 | $20,508,379 | 25,000 | $580,250 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | Summe Gregory L (Director) | Buy | 100,000 | 12.56 | 1,256,000 |
| 2025-08-05 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 3,476 | 11.39 | 39,591 |
| 2025-05-23 | Summe Gregory L (Director) | Buy | 30,000 | 12.50 | 375,000 |
| 2025-05-22 | Summe Gregory L (Director) | Buy | 20,000 | 12.65 | 253,000 |
| 2025-05-07 | Summe Gregory L (Director) | Buy | 25,000 | 12.00 | 300,000 |
| 2025-02-27 | Bramwell James (EVP Sales, Customer Excellence) | Sale | 774 | 17.00 | 13,158 |
| 2025-02-27 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 1,033 | 17.00 | 17,561 |
| 2025-02-26 | Bramwell James (EVP Sales, Customer Excellence) | Sale | 3,758 | 17.53 | 65,877 |
| 2025-02-26 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 4,907 | 17.53 | 86,019 |
| 2024-09-05 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 3,525 | 25.06 | 88,336 |
| 2024-03-08 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 3,685 | 25.63 | 94,446 |
| 2024-02-29 | Bramwell James (EVP Sales, Customer Excellence) | Sale | 4,910 | 24.52 | 120,393 |
| 2024-02-29 | Couturier Christophe (EVP, AMEA) | Sale | 13,074 | 24.53 | 320,705 |
| 2023-09-07 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 7,577 | 20.64 | 156,389 |
| 2023-08-25 | Vanderhaegen Frederic (EVP, Americas and Europe) | Sale | 25,000 | 21.47 | 536,750 |
| 2023-04-11 | Couturier Christophe (EVP, AMEA) | Sale | 1,498 | 21.18 | 31,727 |
| 2023-03-03 | Brophy Gerard (EVP, Biopharma Production) | Sale | 3,914 | 25.00 | 97,850 |
| 2023-02-28 | Couturier Christophe (EVP, AMEA) | Sale | 2,324 | 24.32 | 56,519 |
| 2023-02-27 | Brophy Gerard (EVP, Biopharma Production) | Sale | 3,059 | 25.00 | 76,475 |
| 2023-02-23 | Couturier Christophe (EVP, AMEA) | Sale | 3,078 | 24.24 | 74,610 |
| 2023-02-22 | Couturier Christophe (EVP, AMEA) | Sale | 19,160 | 24.12 | 462,139 |
| 2023-02-02 | Brophy Gerard (EVP, Biopharma Production) | Sale | 11,339 | 25.06 | 284,155 |
| 2022-11-16 | Stubblefield Michael (CEO) | Buy | 30,000 | 20.95 | 628,500 |
| 2022-11-16 | Szlosek Thomas A (EVP & CFO) | Buy | 25,000 | 20.71 | 517,698 |
| 2022-05-23 | Vanderhaegen Frederic (EVP, Americas & Europe) | Sale | 39,000 | 31.61 | 1,232,790 |
| 2022-05-20 | Brophy Gerard (EVP, Biopharma Production) | Sale | 19,603 | 31.27 | 612,985 |
| 2022-03-01 | Brophy Gerard (EVP, Biopharma Production) | Sale | 2,027 | 34.47 | 69,870 |
| 2022-02-23 | Brophy Gerard (EVP, Biopharma Production) | Sale | 3,059 | 33.79 | 103,363 |
| 2022-01-05 | Brophy Gerard (EVP, Biopharma Production) | Sale | 11,551 | 38.65 | 446,446 |
| 2022-01-03 | Brophy Gerard (EVP, Biopharma Production) | Sale | 59,418 | 40.77 | 2,422,471 |
| 2022-01-03 | Brophy Gerard (EVP, Biopharma Production) | Option Ex | 59,418 | 18.45 | 1,096,262 |
| 2021-12-27 | Couturier Christophe (EVP, AMEA) | Sale | 10,184 | 41.63 | 423,959 |
| 2021-12-27 | Couturier Christophe (EVP, AMEA) | Option Ex | 10,184 | 23.21 | 236,370 |
| 2021-12-22 | Couturier Christophe (EVP, AMEA) | Sale | 28,125 | 41.53 | 1,168,031 |
| 2021-12-22 | Couturier Christophe (EVP, AMEA) | Option Ex | 28,125 | 23.21 | 652,781 |
| 2021-12-21 | Couturier Christophe (EVP, AMEA) | Sale | 38,309 | 41.00 | 1,570,669 |
| 2021-12-21 | Couturier Christophe (EVP, AMEA) | Option Ex | 38,309 | 23.21 | 889,151 |
| 2021-12-09 | Couturier Christophe (EVP, AMEA) | Sale | 7,859 | 40.24 | 316,246 |
| 2021-12-09 | Couturier Christophe (EVP, AMEA) | Option Ex | 7,859 | 17.67 | 138,868 |
| 2021-12-08 | Couturier Christophe (EVP, AMEA) | Sale | 5,828 | 40.00 | 233,120 |
| 2021-12-08 | Couturier Christophe (EVP, AMEA) | Option Ex | 5,828 | 17.67 | 102,980 |
| 2021-12-01 | Gupta Rajiv | Sale | 100,000 | 39.30 | 3,929,999 |
| 2021-11-12 | Vanderhaegen Frederic (EVP, Europe) | Sale | 80,000 | 38.25 | 3,060,000 |
| 2021-11-12 | Vanderhaegen Frederic (EVP, Europe) | Option Ex | 80,000 | 23.20 | 1,856,000 |
| 2021-11-11 | Vanderhaegen Frederic (EVP, Europe) | Sale | 60,804 | 38.41 | 2,335,481 |
| 2021-11-01 | Gupta Rajiv | Sale | 100,000 | 40.31 | 4,031,000 |
| 2021-10-01 | Gupta Rajiv | Sale | 100,000 | 39.94 | 3,994,000 |
| 2021-09-20 | Stubblefield Michael (President and CEO) | Sale | 141,300 | 42.37 | 5,986,881 |
| 2021-09-01 | Gupta Rajiv | Sale | 100,000 | 39.45 | 3,945,000 |
| 2021-08-26 | Eck Steven W (SVP & Chief Accounting Officer) | Sale | 17,383 | 40.08 | 696,710 |
| 2021-08-20 | Gupta Rajiv | Sale | 100,000 | 38.81 | 3,881,000 |
| 2021-07-30 | Brophy Gerard (EVP, Biopharma Production) | Sale | 81,125 | 37.24 | 3,021,095 |
| 2021-07-30 | Brophy Gerard (EVP, Biopharma Production) | Option Ex | 81,125 | 23.20 | 1,882,100 |
| 2021-07-20 | Bramwell James (EVP, Strategic Partners) | Sale | 6,112 | 37.00 | 226,144 |
| 2021-07-12 | Natauri Jo (Director) | Buy | 300 | 36.33 | 10,900 |
| 2021-07-09 | Bramwell James (EVP, Strategic Partners) | Sale | 18,331 | 35.60 | 652,583 |
| 2021-06-25 | Gupta Rajiv | Sale | 68,605 | 35.32 | 2,423,128 |
| 2021-06-10 | Stubblefield Michael (President and CEO) | Sale | 99,887 | 32.48 | 3,244,329 |
| 2021-06-10 | Stubblefield Michael (President and CEO) | Option Ex | 99,887 | 3.66 | 365,586 |
| 2021-06-09 | Stubblefield Michael (President and CEO) | Sale | 235,170 | 32.03 | 7,532,495 |
| 2021-06-09 | Stubblefield Michael (President and CEO) | Option Ex | 235,170 | 3.13 | 736,082 |
| 2021-06-08 | Stubblefield Michael (President and CEO) | Sale | 152,643 | 32.04 | 4,890,681 |
| 2021-06-08 | Stubblefield Michael (President and CEO) | Option Ex | 152,643 | 3.13 | 477,772 |
| 2021-05-27 | Gupta Rajiv | Sale | 78,109 | 31.94 | 2,494,801 |
| 2021-05-26 | Gupta Rajiv | Sale | 150,000 | 31.89 | 4,783,500 |
| 2021-05-24 | Gupta Rajiv | Sale | 337,571 | 31.66 | 10,685,810 |
| 2021-05-21 | Wondrasch Michael (EVP & CIO) | Sale | 18,488 | 31.41 | 580,708 |
| 2021-05-20 | Miller Justin (EVP & General Counsel) | Sale | 18,488 | 31.12 | 575,346 |
| 2021-05-20 | Brophy Gerard (EVP, Biopharma Production) | Sale | 19,603 | 31.10 | 609,653 |
| 2021-05-20 | Couturier Christophe (EVP, AMEA) | Sale | 25,010 | 31.13 | 778,561 |
| 2021-05-14 | Ohri Devashish (EVP, IMEA) | Option Ex | 25,000 | 23.21 | 580,250 |
| 2021-04-30 | Ohri Devashish (EVP, IMEA) | Sale | 53,649 | 32.58 | 1,747,884 |
| 2021-04-30 | Ohri Devashish (EVP, IMEA) | Option Ex | 53,649 | 23.21 | 1,245,193 |
| 2021-04-12 | Vanderhaegen Frederic (EVP, Europe) | Sale | 27,075 | 31.79 | 860,714 |
| 2021-04-12 | Ohri Devashish (EVP, IMEA) | Sale | 100,160 | 32.37 | 3,242,179 |
| 2021-04-12 | Ohri Devashish (EVP, IMEA) | Option Ex | 100,160 | 1.60 | 160,256 |
| 2021-04-12 | Miller Justin (EVP & General Counsel) | Sale | 102,895 | 32.48 | 3,342,029 |
| 2021-04-12 | Miller Justin (EVP & General Counsel) | Option Ex | 100,000 | 23.21 | 2,321,000 |
| 2021-04-12 | Bramwell James (EVP, Strategic Partners) | Sale | 2,505 | 32.00 | 80,160 |
| 2021-03-09 | Vanderhaegen Frederic (EVP, Europe) | Sale | 10,000 | 28.21 | 282,100 |
| 2021-03-02 | Wondrasch Michael (EVP & CIO) | Sale | 3,036 | 28.71 | 87,163 |
| 2021-02-24 | Brophy Gerard (EVP, Biopharma Production) | Sale | 3,059 | 27.93 | 85,437 |
| 2021-02-24 | Eck Steven W (SVP & Chief Accounting Officer) | Option Ex | 8,550 | .00 | 0 |
| 2021-02-22 | Brophy Gerard (EVP, Biopharma Production) | Sale | 19,769 | 28.62 | 565,788 |
| 2021-02-22 | Brophy Gerard (EVP, Biopharma Production) | Option Ex | 19,769 | 17.67 | 349,318 |
| 2021-02-05 | Wondrasch Michael (EVP & CIO) | Sale | 49,468 | 29.77 | 1,472,662 |
| 2021-02-05 | Wondrasch Michael (EVP & CIO) | Option Ex | 40,000 | 23.20 | 928,000 |
| 2021-01-11 | Brophy Gerard (EVP, Biopharma Production) | Sale | 378,580 | 30.06 | 11,380,114 |
| 2021-01-11 | Brophy Gerard (EVP, Biopharma Production) | Option Ex | 378,580 | 23.20 | 8,783,056 |
| 2021-01-11 | Bramwell James (EVP, Strategic Partners) | Sale | 2,505 | 30.00 | 75,150 |
| 2021-01-06 | Brophy Gerard (EVP, Biopharma Production) | Sale | 11,509 | 27.24 | 313,505 |
| 2021-01-04 | Brophy Gerard (EVP, Biopharma Production) | Sale | 59,418 | 27.84 | 1,654,197 |
| 2021-01-04 | Brophy Gerard (EVP, Biopharma Production) | Option Ex | 59,418 | 18.45 | 1,096,262 |
| 2020-12-21 | Bramwell James (EVP, Strategic Partners) | Sale | 10,020 | 27.14 | 271,942 |
| 2020-12-11 | Shaw Christi | Sale | 14,286 | 26.68 | 381,150 |
| 2020-12-07 | Stubblefield Michael (President and CEO) | Sale | 98,452 | 27.45 | 2,702,507 |
| 2020-12-07 | Stubblefield Michael (President and CEO) | Option Ex | 210,369 | 1.60 | 336,590 |
| 2020-12-04 | Stubblefield Michael (President and CEO) | Sale | 412,188 | 27.08 | 11,162,051 |
| 2020-12-04 | Stubblefield Michael (President and CEO) | Option Ex | 880,601 | 1.60 | 1,408,961 |
| 2020-11-10 | Klinsky Steven B (10% Owner) | Sale | 36,016,093 | 24.81 | 893,487,235 |
| 2020-10-05 | Ohri Devashish (EVP, IMEA) | Sale | 103,440 | 23.45 | 2,425,357 |
| 2020-10-05 | Ohri Devashish (EVP, IMEA) | Option Ex | 103,440 | 1.60 | 165,504 |
| 2020-09-16 | Ohri Devashish (EVP, IMEA) | Sale | 35,000 | 23.02 | 805,700 |
| 2020-09-16 | Ohri Devashish (EVP, IMEA) | Option Ex | 35,000 | 1.60 | 56,000 |
| 2020-09-08 | Miller Justin (EVP & General Counsel) | Sale | 22,887 | 21.17 | 484,517 |
| 2020-08-21 | Klinsky Steven B (10% Owner) | Sale | 25,575,472 | 19.51 | 498,900,732 |
| 2020-08-19 | Gupta Rajiv | Option Ex | 1,147,970 | 1.60 | 1,836,752 |
| 2020-08-01 | Natauri Jo | Sale | 15,397,005 | 19.51 | 300,349,376 |
| 2020-08-01 | Stonebridge 2018, L.p. | Sale | 15,397,005 | 19.51 | 300,349,376 |
| 2020-07-30 | Ohri Devashish (EVP, IMEA) | Sale | 35,000 | 21.37 | 747,950 |
| 2020-07-30 | Ohri Devashish (EVP, IMEA) | Option Ex | 35,000 | 1.60 | 56,000 |
| 2020-05-29 | Ohri Devashish (EVP, IMEA) | Sale | 65,000 | 18.82 | 1,223,300 |
| 2020-05-29 | Ohri Devashish (EVP, IMEA) | Option Ex | 65,000 | 1.60 | 104,000 |
| 2020-05-26 | Klinsky Steven B (10% Owner) | Sale | 20,886,424 | 15.90 | 332,198,573 |
| 2020-05-22 | Wondrasch Michael (EVP & CIO) | Sale | 22,987 | 17.82 | 409,628 |
| 2020-05-20 | Brophy Gerard (EVP, Biopharma Production) | Sale | 25,495 | 17.36 | 442,593 |
| 2020-05-01 | Connolly Thomas | Sale | 13,726,411 | 15.90 | 218,249,934 |
| 2020-05-01 | Natauri Jo | Sale | 13,726,411 | 15.90 | 218,249,934 |
| 2020-05-01 | Stonebridge 2018 Offshore, L.p. | Sale | 13,726,411 | 15.90 | 218,249,934 |
| 2020-03-12 | Stubblefield Michael (CEO) | Option Ex | 200,000 | 1.60 | 320,000 |
| 2020-03-10 | Gupta Rajiv | Option Ex | 143,000 | 1.60 | 228,800 |
| 2020-02-18 | Ohri Devashish (EVP, IMEA) | Sale | 20,000 | 17.54 | 350,800 |
| 2020-02-18 | Ohri Devashish (EVP, IMEA) | Option Ex | 20,000 | 1.60 | 32,000 |
| 2019-09-25 | Connolly Thomas (Director) | Buy | 25,000 | 14.77 | 369,250 |
| 2019-09-25 | Connolly Thomas (Director) | Sale | 25,000 | 14.77 | 369,250 |
| 2019-09-25 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 25,000 | 14.77 | 369,250 |
| 2019-09-25 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 25,000 | 14.77 | 369,250 |
| 2019-09-09 | Connolly Thomas (Director) | Buy | 149,694 | 16.46 | 2,463,514 |
| 2019-09-09 | Connolly Thomas (Director) | Sale | 149,694 | 16.46 | 2,463,514 |
| 2019-09-09 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 149,694 | 16.46 | 2,463,514 |
| 2019-09-09 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 149,694 | 16.46 | 2,463,514 |
| 2019-09-06 | Connolly Thomas (Director) | Buy | 116,637 | 16.79 | 1,958,218 |
| 2019-09-06 | Connolly Thomas (Director) | Sale | 116,637 | 16.79 | 1,958,218 |
| 2019-09-06 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 116,637 | 16.79 | 1,958,218 |
| 2019-09-06 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 116,637 | 16.79 | 1,958,218 |
| 2019-08-12 | Connolly Thomas (Director) | Buy | 16,254 | 16.59 | 269,605 |
| 2019-08-12 | Connolly Thomas (Director) | Sale | 16,254 | 16.59 | 269,605 |
| 2019-08-12 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 16,254 | 16.59 | 269,605 |
| 2019-08-12 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 16,254 | 16.59 | 269,605 |
| 2019-08-06 | Connolly Thomas (Director) | Buy | 88 | 16.66 | 1,466 |
| 2019-08-06 | Connolly Thomas (Director) | Sale | 88 | 16.66 | 1,466 |
| 2019-08-06 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 88 | 16.66 | 1,466 |
| 2019-08-06 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 88 | 16.66 | 1,466 |
| 2019-07-31 | Connolly Thomas (Director) | Buy | 55 | 17.55 | 965 |
| 2019-07-31 | Connolly Thomas (Director) | Sale | 55 | 17.55 | 965 |
| 2019-07-31 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 55 | 17.55 | 965 |
| 2019-07-31 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 55 | 17.55 | 965 |
| 2019-05-21 | Peacock Jonathan M (Director) | Option Ex | 117,857 | .00 | 0 |
| 2019-05-21 | Gupta Rajiv (Director) | Option Ex | 523,286 | .00 | 0 |
| 2019-05-21 | Klinsky Steven B (10% Owner) | Sale | 100 | 14.00 | 1,400 |
| 2019-05-17 | Connolly Thomas (Director) | Buy | 13,099 | 14.00 | 183,386 |
| 2019-05-17 | Connolly Thomas (Director) | Sale | 14,049 | 14.00 | 196,686 |
| 2019-05-17 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Buy | 13,099 | 14.00 | 183,386 |
| 2019-05-17 | Stonebridge 2018 Offshore, L.p. (10% Owner) | Sale | 14,049 | 14.00 | 196,686 |
Insider trading activities including stock purchases, stock sales, and option exercises of AVTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avantor, Inc. (symbol AVTR, CIK number 1722482) see the Securities and Exchange Commission (SEC) website.